208 related articles for article (PubMed ID: 23516355)
21. Up-regulation of NFkappaB-responsive gene expression by DeltaNp73alpha in p53 null cells.
Tanaka Y; Ota K; Kameoka M; Itaya A; Yoshihara K
Exp Cell Res; 2006 May; 312(8):1254-64. PubMed ID: 16430884
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus induces global changes in cellular mRNA isoform usage that are important for the maintenance of latency.
Homa NJ; Salinas R; Forte E; Robinson TJ; Garcia-Blanco MA; Luftig MA
J Virol; 2013 Nov; 87(22):12291-301. PubMed ID: 24027308
[TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus LMP2A suppresses MHC class II expression by regulating the B-cell transcription factors E47 and PU.1.
Lin JH; Lin JY; Chou YC; Chen MR; Yeh TH; Lin CW; Lin SJ; Tsai CH
Blood; 2015 Apr; 125(14):2228-38. PubMed ID: 25631773
[TBL] [Abstract][Full Text] [Related]
24. Interferon regulatory factor 7: a key cellular mediator of LMP-1 in EBV latency and transformation.
Zhang L; Pagano JS
Semin Cancer Biol; 2001 Dec; 11(6):445-53. PubMed ID: 11669606
[TBL] [Abstract][Full Text] [Related]
25. Antisense to the Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) sensitizes EBV-immortalized B cells to transforming growth factor-beta and chemotherapeutic agents.
Kenney JL; Guinness ME; Reiss M; Lacy J
Int J Cancer; 2001 Jan; 91(1):89-98. PubMed ID: 11149426
[TBL] [Abstract][Full Text] [Related]
26. Tumor Suppressor p53 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1.
Wang Q; Lingel A; Geiser V; Kwapnoski Z; Zhang L
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794023
[TBL] [Abstract][Full Text] [Related]
27. EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53.
Le Clorennec C; Youlyouz-Marfak I; Adriaenssens E; Coll J; Bornkamm GW; Feuillard J
Blood; 2006 Mar; 107(5):2070-8. PubMed ID: 16317104
[TBL] [Abstract][Full Text] [Related]
28. IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter.
Kis LL; Salamon D; Persson EK; Nagy N; Scheeren FA; Spits H; Klein G; Klein E
Proc Natl Acad Sci U S A; 2010 Jan; 107(2):872-7. PubMed ID: 20080768
[TBL] [Abstract][Full Text] [Related]
29. The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells.
Forte E; Salinas RE; Chang C; Zhou T; Linnstaedt SD; Gottwein E; Jacobs C; Jima D; Li QJ; Dave SS; Luftig MA
J Virol; 2012 Jun; 86(12):6889-98. PubMed ID: 22496226
[TBL] [Abstract][Full Text] [Related]
30. EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance.
Gordadze AV; Onunwor CW; Peng R; Poston D; Kremmer E; Ling PD
J Virol; 2004 Apr; 78(8):3919-29. PubMed ID: 15047808
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site.
Sandvej K; Andresen BS; Zhou XG; Gregersen N; Hamilton-Dutoit S
Mol Pathol; 2000 Oct; 53(5):280-8. PubMed ID: 11091852
[TBL] [Abstract][Full Text] [Related]
32. EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX.
Grimm T; Schneider S; Naschberger E; Huber J; Guenzi E; Kieser A; Reitmeir P; Schulz TF; Morris CA; Stürzl M
Blood; 2005 Apr; 105(8):3263-9. PubMed ID: 15613549
[TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus EBNA-3C is targeted to and regulates expression from the bidirectional LMP-1/2B promoter.
Jiménez-Ramírez C; Brooks AJ; Forshell LP; Yakimchuk K; Zhao B; Fulgham TZ; Sample CE
J Virol; 2006 Nov; 80(22):11200-8. PubMed ID: 16956945
[TBL] [Abstract][Full Text] [Related]
34. c-Myc Represses Transcription of Epstein-Barr Virus Latent Membrane Protein 1 Early after Primary B Cell Infection.
Price AM; Messinger JE; Luftig MA
J Virol; 2018 Jan; 92(2):. PubMed ID: 29118124
[TBL] [Abstract][Full Text] [Related]
35. DeltaNp73alpha regulates MDR1 expression by inhibiting p53 function.
Vilgelm A; Wei JX; Piazuelo MB; Washington MK; Prassolov V; El-Rifai W; Zaika A
Oncogene; 2008 Apr; 27(15):2170-6. PubMed ID: 17952118
[TBL] [Abstract][Full Text] [Related]
36. Characterization of intercellular adhesion molecule-1 regulation by Epstein-Barr virus-encoded latent membrane protein-1 identifies pathways that cooperate with nuclear factor kappa B to activate transcription.
Mehl AM; Floettmann JE; Jones M; Brennan P; Rowe M
J Biol Chem; 2001 Jan; 276(2):984-92. PubMed ID: 11034993
[TBL] [Abstract][Full Text] [Related]
37. The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation.
Izumi KM; Cahir McFarland ED; Riley EA; Rizzo D; Chen Y; Kieff E
J Virol; 1999 Dec; 73(12):9908-16. PubMed ID: 10559303
[TBL] [Abstract][Full Text] [Related]
38. Cross-talks in the p53 family: deltaNp63 is an anti-apoptotic target for deltaNp73alpha and p53 gain-of-function mutants.
Lanza M; Marinari B; Papoutsaki M; Giustizieri ML; D'Alessandra Y; Chimenti S; Guerrini L; Costanzo A
Cell Cycle; 2006 Sep; 5(17):1996-2004. PubMed ID: 16931914
[TBL] [Abstract][Full Text] [Related]
39. EBNA3C facilitates RASSF1A downregulation through ubiquitin-mediated degradation and promoter hypermethylation to drive B-cell proliferation.
Zhang S; Pei Y; Lang F; Sun K; Singh RK; Lamplugh ZL; Saha A; Robertson ES
PLoS Pathog; 2019 Jan; 15(1):e1007514. PubMed ID: 30615685
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of Toll-Like Receptor 9 Expression by Beta Human Papillomavirus 38 and Implications for Cell Cycle Control.
Pacini L; Savini C; Ghittoni R; Saidj D; Lamartine J; Hasan UA; Accardi R; Tommasino M
J Virol; 2015 Nov; 89(22):11396-405. PubMed ID: 26339055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
